144 related articles for article (PubMed ID: 33657249)
21. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
Chiu K; Ionescu DN; Hayes M
Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
[TBL] [Abstract][Full Text] [Related]
22. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
[TBL] [Abstract][Full Text] [Related]
23. Regulation of in situ to invasive breast carcinoma transition.
Hu M; Yao J; Carroll DK; Weremowicz S; Chen H; Carrasco D; Richardson A; Violette S; Nikolskaya T; Nikolsky Y; Bauerlein EL; Hahn WC; Gelman RS; Allred C; Bissell MJ; Schnitt S; Polyak K
Cancer Cell; 2008 May; 13(5):394-406. PubMed ID: 18455123
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
Rohilla M; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
[TBL] [Abstract][Full Text] [Related]
25. The nuclear coactivator amplified in breast cancer 1 maintains tumor-initiating cells during development of ductal carcinoma in situ.
Ory V; Tassi E; Cavalli LR; Sharif GM; Saenz F; Baker T; Schmidt MO; Mueller SC; Furth PA; Wellstein A; Riegel AT
Oncogene; 2014 Jun; 33(23):3033-42. PubMed ID: 23851504
[TBL] [Abstract][Full Text] [Related]
26. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic alterations in myoepithelial cells of the breast in normal and pathologic conditions.
Pusztaszeri M
Am J Surg Pathol; 2010 Dec; 34(12):1886; author reply 1886-7. PubMed ID: 21107098
[No Abstract] [Full Text] [Related]
28. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic study of infiltrating epitheliosis of the breast].
Xu XL; Tu XY; Shui RH; Cheng YF; Yu BH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):827-831. PubMed ID: 29224275
[No Abstract] [Full Text] [Related]
30. Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup.
Shekhar MP; Kato I; Nangia-Makker P; Tait L
Oncotarget; 2013 Feb; 4(2):231-41. PubMed ID: 23548208
[TBL] [Abstract][Full Text] [Related]
31. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
32. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.
Barsky SH; Karlin NJ
Nat Clin Pract Oncol; 2006 Mar; 3(3):138-51. PubMed ID: 16520804
[TBL] [Abstract][Full Text] [Related]
34. Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization.
Hildenbrand R; Leitz M; Magdolen V; Luther T; Albrecht S; Graeff H; Stutte HJ; Bleyl U; Schmitt M
Histopathology; 2000 Jun; 36(6):499-504. PubMed ID: 10849091
[TBL] [Abstract][Full Text] [Related]
35. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
[TBL] [Abstract][Full Text] [Related]
36. Invasion in breast lesions: the role of the epithelial-stroma barrier.
Rakha EA; Miligy IM; Gorringe KL; Toss MS; Green AR; Fox SB; Schmitt FC; Tan PH; Tse GM; Badve S; Decker T; Vincent-Salomon A; Dabbs DJ; Foschini MP; Moreno F; Wentao Y; Geyer FC; Reis-Filho JS; Pinder SE; Lakhani SR; Ellis IO
Histopathology; 2018 Jun; 72(7):1075-1083. PubMed ID: 29197112
[TBL] [Abstract][Full Text] [Related]
37. Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.
Rossetti S; Bshara W; Reiners JA; Corlazzoli F; Miller A; Sacchi N
Cancer Lett; 2016 Oct; 380(2):375-383. PubMed ID: 27422542
[TBL] [Abstract][Full Text] [Related]
38. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
[TBL] [Abstract][Full Text] [Related]
39. Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion.
Szynglarewicz B; Kasprzak P; Donizy P; Biecek P; Halon A; Matkowski R
J Surg Oncol; 2016 Oct; 114(5):548-556. PubMed ID: 27439354
[TBL] [Abstract][Full Text] [Related]
40. A novel myoepithelial/progenitor cell marker in the breast?
Kolar Z; Ehrmann J; Turashvili G; Bouchal J; Mokry J
Virchows Arch; 2007 May; 450(5):607-9. PubMed ID: 17429688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]